Patents by Inventor Kelly Dodge

Kelly Dodge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DR4 ANTIBODIES AND USES THEREOF
    Publication number: 20110002933
    Abstract: Death Receptor 4 (DR4) antibodies are provided. The DR4 antibodies may be included in pharmaceutical compositions, articles of manufacture, or kits. Methods of treatment and diagnosis using the DR4 antibodies are also provided.
    Type: Application
    Filed: September 24, 2009
    Publication date: January 6, 2011
    Inventors: AVI ASHKENAZI, ANAN CHUNTHARAPAI, KELLY DODGE, KYUNG JIN KIM
  • DR4 antibodies and uses thereof
    Publication number: 20080095700
    Abstract: Death Receptor 4 (DR4) antibodies are provided. The DR4 antibodies may be included in pharmaceutical compositions, articles of manufacture, or kits. Methods of treatment and diagnosis using the DR4 antibodies are also provided.
    Type: Application
    Filed: May 9, 2007
    Publication date: April 24, 2008
    Inventors: Avi Ashkenazi, Anan Chuntharapai, Kelly Dodge, Kyung Kim
  • Uses of agonists and antagonists to modulate activity of TNF-related molecules
    Publication number: 20060073146
    Abstract: Methods of using one or more agonists or antagonists to modulate activity of the members of the TNF and TNFR families referred to as TALL-1, APRIL, TACI, and BCMA are provided. The methods include in vitro, in situ, and/or in vivo diagnosis and/or treatment of mammalian cells or pathological conditions associated with TALL-1, APRIL, TACI, or BCMA, using one or more agonist or antagonist molecules. The methods of treatment disclosed by the invention include methods of treating immune related diseases and cancer.
    Type: Application
    Filed: February 28, 2005
    Publication date: April 6, 2006
    Inventors: Avi Ashkenazi, Kelly Dodge, Iqbal Grewal, Kyung Kim, Scot Marsters, Robert Pitti, Minhong Yan
  • DR4 antibodies and uses thereof
    Publication number: 20040120947
    Abstract: Death Receptor 4 (DR4) antibodies are provided. The DR4 antibodies may be included in pharmaceutical compositions, articles of manufacture, or kits. Methods of treatment and diagnosis using the DR4 antibodies are also provided.
    Type: Application
    Filed: September 11, 2003
    Publication date: June 24, 2004
    Applicant: Genentech, Inc.
    Inventors: Avi Ashkenazi, Anan Chuntharapai, Kelly Dodge, Kyung Jin Kim